Author: Shannon Palus

Top official at Indian university plagiarized most of paper

b048e927307f7f40d344616e30a06edb

A top official and law researcher at a university in India is facing dismissal after being charged with plagiarizing approximately three-quarters of one of her papers, among other allegations.

Chandra Krishnamurthy, the Vice Chancellor at Pondicherry University, has been “placed under ‘compulsory wait’ by the Union human resource ministry following several charges against her,” according to The Times of India.

A nine-month long investigation by the International Journal of Legal Information confirmed that the majority of one paper on Krishnamurthy’s CV, “Legal Education and Legal Profession in India,” was largely plagiarized.

Here’s the retraction note:
Continue reading Top official at Indian university plagiarized most of paper

Re-analysis of controversial Paxil study shows drug “ineffective and unsafe” for teens

downloadThe antidepressant Paxil isn’t safe or effective for teens after all, says a re-analysis of a 2001 study published today in The BMJ.

The original 2001 paper in Journal of the American Academy of Child and Adolescent Psychiatry — study 329, as it’s known — helped greenlight use of the drug (generically known as paroxetine) in young people. But it’s faced accusations of ghostwriting, undisclosed conflicts of interest, and issues with data analysis since publication.

According to a BMJ feature, also published today: Continue reading Re-analysis of controversial Paxil study shows drug “ineffective and unsafe” for teens

Fourth retraction for Einstein oncologist due to image manipulations

home_cover (1)Two papers on a potential cancer drug have been retracted following an investigation that found “inappropriate manipulation of bands in gels.”

This makes four retractions by our count for Roman Perez-Soler, an oncologist at the Einstein College of Medicine, and for co-author Yi-He Ling, whose current affiliation is unknown.

Their previous two retractions, which we reported on in 2013, were also for image manipulation. At the time, Perez-Soler told us that Ling “accepted full responsibility for the changes” and he had “returned to his home country.”

The fresh retraction notes, from Molecular Pharmacology, provide a few specifics about the figures that were manipulated this time around.

Continue reading Fourth retraction for Einstein oncologist due to image manipulations

Plagiarism count for mathematician updated to four papers

S00220396After we reported on a retraction for a 13-year old paper by Mohammed Aassila, a reader alerted us to two retractions and an editorial notice for the mathematician. Each of the notes is several years old.

That makes a total of four problematic papers for Aassila. Each is plagued by the same thing: plagiarism.

Here is the retraction note for “The influence of nonlocal nonlinearities on the long time behavior of solutions of diffusion problems,” published in the Journal of Differential Equations:

Continue reading Plagiarism count for mathematician updated to four papers

“Fabricated results” retract JAMA clinical trial, plus a sub-analysis of the data

Screen Shot 2015-09-14 at 11.00.11 AMA JAMA clinical trial that suggested a blood pressure drug could help patients increase their physical fitness, and a sub-analysis of those data, have been retracted after “an admission of fabricated results” by the first author on both papers.

The three-year clinical trial was published in JAMA in 2013.  It was retracted this morning.

The trial found ramipril helped patients with artery disease walk longer and with less pain, according to the abstract:

Among patients with intermittent claudication, 24-week treatment with ramipril resulted in significant increases in pain-free and maximum treadmill walking times compared with placebo. This was associated with a significant increase in the physical functioning component of the SF-36 score.

The retraction note explains how the fabricated data came to light: 

Continue reading “Fabricated results” retract JAMA clinical trial, plus a sub-analysis of the data

Anti-fish oil researcher netted two more retractions

Screen Shot 2015-08-17 at 10.11.25 AM
Brian Peskin

Earlier this year, Food and Nutrition Sciences retracted two papers from an author who criticized highly popular fish oil supplements after an additional round of peer review concluded his papers present a “biased interpretation,” among other issues.

Last year, Brian Peskin lost a paper for an “undeclared competing interest” — namely, that he held patents and directed a company associated with essential fatty acids.

In place of fish oil, Peskin touts plant-based supplements for treating cardiovascular disease. From the abstract of the freshly-retracted “Why Fish Oil Fails to Prevent or Improve CVD: A 21st Century Analysis,” he claims that Parent Essential Oils (PEOs) — such as alpha-linolenic acid, which can be converted into the EPA and DHA found in fish oil — “fulfill fish oil’s failed promise”: Continue reading Anti-fish oil researcher netted two more retractions

Divorce study felled by a coding error gets a second chance

home_cover (1)A journal has published a corrected version of a widely reported study linking severe illness and divorce rates after it was retracted in July due to a small coding error.

The original, headline-spawning conclusion was that the risk of divorce in a heterosexual marriage increases when the wife falls ill, but not the husband. The revised results — published again in the Journal of Health and Social Behavior, along with lengthy explanations from the authors and editors — are more nuanced: Gender only significantly correlates with divorce rate in the case of heart disease.

The authors’ note, from Iowa State’s Amelia Karraker and Kenzie Latham, at Indiana University-Purdue University Indianapolis, explains that the coding error led them to over-estimate how many marriages ended in divorce:

Continue reading Divorce study felled by a coding error gets a second chance

“Obviously stolen” figure squashes mosquito paper in author’s second retraction

jmr-cover2015The Journal of Mosquito Research has retracted a paper because it contains a figure that “was obviously stolen” from another paper.

The retracted paper’s first author Emtithal M. Abd El-Samiee is now up to two retractions, by our count. Last month, we reported on her fruit fly paper, felled by a faulty gene sequence. On the paper, she is listed as an entomologist at Cairo University.

The note tells us where the figure was stolen from:

Continue reading “Obviously stolen” figure squashes mosquito paper in author’s second retraction

Former accounting prof adds his 32nd retraction

james-hunton
James Hunton

Another retraction makes 32.5 for former accounting professor James E. Hunton, and earns him the #10 slot on our leaderboard.

Though he resigned from his position at Bentley University in 2012, the story didn’t end there: In 2014, a university investigation found he’d committed misconduct in two papers. The, in June 2015, he notched 25 retractions all at once.

The newly retracted paper, “Effects of Anonymous Whistle- Blowing and Perceived Reputation Threats on Investigations of Whistle-Blowing Allegations by Audit Committee Members,” published in the Journal of Management Studies, suggests that, for public corporations, an anonymous whistleblower might not be as effective as an alert from a known source. The publisher Wiley put out a press release for the paper in 2010, and it succeeded in garnering some coverage.

Whether its conclusion remains valid is unclear, as Hunton didn’t provide evidence to support the validity of the data. The note explains:

Continue reading Former accounting prof adds his 32nd retraction

Plant paper pulled when authors can’t pay fees

KPSB_10_08_COVER.inddA paper on chicory plants — also known as “blue daisies” — won’t get its moment in the sun.

The “accepted author version” was published online in June, in Plant Signaling & Behavior. But before the so-called “version of record” could make it into an official issue of the journal — which is online-only — it was retracted.

Why? The authors apparently couldn’t pay the fees required to publish the paper. Here’s the short note, which is titled “Editorial Retraction:” Continue reading Plant paper pulled when authors can’t pay fees